Advertisement
U.S. Markets open in 6 hrs 59 mins

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

NSE - NSE Real Time Price. Currency in INR
1,895.10-1.90 (-0.10%)
As of 12:01PM IST. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
484,978,100
477,584,500
432,788,700
384,264,200
332,330,800
Cost of Revenue
119,869,200
120,696,600
119,424,200
103,515,400
98,854,200
Gross Profit
365,108,900
356,887,900
313,364,500
280,748,800
233,476,600
Operating Expense
257,181,800
252,206,100
220,590,900
199,748,600
169,334,200
Operating Income
107,927,100
104,681,800
92,773,600
81,000,200
64,142,400
Net Non Operating Interest Income Expense
8,037,800
7,844,400
2,125,400
-1,273,500
700,400
Pretax Income
120,302,500
110,878,900
94,084,300
44,813,200
27,993,700
Tax Provision
15,236,000
14,394,500
8,475,900
10,755,000
5,146,900
Net Income Common Stockholders
103,894,600
95,763,800
84,735,800
32,727,300
29,038,200
Diluted NI Available to Com Stockholders
103,894,600
95,763,800
84,735,800
32,727,300
29,038,200
Basic EPS
35.60
39.90
35.30
13.60
12.10
Diluted EPS
35.60
39.90
35.30
13.60
12.10
Basic Average Shares
2,401,239
2,399,335
2,399,335
2,406,419
2,399,335
Diluted Average Shares
2,401,239
2,399,335
2,399,335
2,406,419
2,399,335
Rent Expense Supplemental
-
734,300
588,700
535,400
419,800
Total Expenses
377,051,000
372,902,700
340,015,100
303,264,000
268,188,400
Net Income from Continuing & Discontinued Operation
103,894,600
95,763,800
84,735,800
32,727,300
29,038,200
Normalized Income
104,661,229
99,337,187
86,386,835
67,435,683
61,957,565
Interest Income
-
10,229,100
3,845,400
5,533,700
2,111,300
Interest Expense
2,191,300
2,384,700
1,720,000
1,273,500
1,410,900
Net Interest Income
8,037,800
7,844,400
2,125,400
-1,273,500
700,400
EBIT
122,493,800
113,263,600
95,804,300
46,086,700
29,404,600
EBITDA
148,098,300
138,831,500
121,108,600
67,524,100
50,204,100
Reconciled Cost of Revenue
119,869,200
120,696,600
119,424,200
103,515,400
98,854,200
Reconciled Depreciation
25,604,500
25,567,900
25,304,300
21,437,400
20,799,500
Net Income from Continuing Operation Net Minority Interest
103,894,600
95,763,800
84,735,800
32,727,300
29,038,200
Total Unusual Items Excluding Goodwill
-877,800
-4,106,500
-1,814,500
-45,668,700
-40,335,400
Total Unusual Items
-877,800
-4,106,500
-1,814,500
-45,668,700
-40,335,400
Normalized EBITDA
148,976,100
142,938,000
122,923,100
113,192,800
90,539,500
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-111,171
-533,113
-163,465
-10,960,317
-7,416,035